The Use of Lasers for the Surgical Treatment of Benign Prostate Hyperplasia

2012 ◽  
Vol 3 (1) ◽  
pp. 1-6
Author(s):  
Cenk Gurbuz ◽  
Turhan Caskurlu
2003 ◽  
Author(s):  
Werner T. W. de Riese ◽  
Thomas Nelius ◽  
David R. Aronoff ◽  
Bernhard T. Mittemeyer

2013 ◽  
Vol 12 (4) ◽  
pp. e1285, C177a-e1285, C177b
Author(s):  
M.K. Alchinbayev ◽  
M.A. Malikh ◽  
M.T. Batyrbekov ◽  
K.M. Abdilmanov ◽  
I.B. Mansurova

2020 ◽  
Vol 8 (4) ◽  
pp. 495-501
Author(s):  
I.S. Sobennikov ◽  
◽  
V.B. Filimonov ◽  
R.V. Vasin ◽  
◽  
...  

Aim. To study the status of provision of planned and urgent care to patients with benign prostate hyperplasia (BPH) in round-the-clock urological hospitals of the Ryazan region in recent 5 years. Materials and Methods. Statistical processing of the data for 2015-2020 obtained from medical statistics services of urological hospitals of Ryazan was performed. The following parameters were studied: the average age of patients who turned to emergency room with the diagnosis of acute retention of urine; the amount of surgical interventions (cystectomies) per months and years of the reporting period: open adenomectomy (in the following modifications: transvesical ade-nomectomy, retropubic adenomectomy), transurethral resection of prostate. Results. A high amount of referral of patients with BPH with clinical symptoms of acute reten-tion of urine was identified. The quantity and the share of palliative surgeries in the structure of patients with BPH stays at a high level. A tendency to growth in the amount of minimally inva-sive operations in surgical treatment for BPH is noted. Conclusion. The analysis of statistical data indicates the need for improvement of the quality of dispensary observation of patients with BPH, and improvement of methods of minimally inva-sive surgical treatment of BPH.


2020 ◽  
Author(s):  
Ki Hong Kim ◽  
Si Hyun Kim ◽  
Hee Jo Yang ◽  
Doo Sang Kim ◽  
Chang Ho Lee ◽  
...  

Abstract Background: To identify predictive factors for favorable outcomes after surgical treatments that were performed by beginner urologists in patients with benign prostate hyperplasia (BPH), we retrospectively evaluated outcomes after holmium laser enucleation of the prostate (HoLEP) and transurethral resection of prostate (TURP) that were performed by two young urologists.Methods: Of 80 patients who were treated with HoLEP or TURP, 31 (HoLEP) and 36 (TURP) patients who were followed up for 3 months were enrolled in this study. Preoperative and perioperative variables were evaluated to identify predictive factors for favorable outcome after surgical treatment for BPH.Results: At 3 months postoperative after HoLEP or TURP, the median decrease in IPSS was 13.0. Patients whose IPSS decreased by over 13 points were categorized into a favorable response group after HoLEP or TURP. Univariate and multivariate logistic regression analyses were performed to identify predictors of favorable outcomes at 3 months after HoLEP or TURP, and the preoperative IPSS was identified as an independent predictor for favorable outcomes. Conclusions: When young urologists plan to perform surgical treatment for BPH, they should consider that the severity of symptoms is the most important factor for favorable outcomes. The type of surgical modality for managing BPH is less important. Trial registration : Soonchunhyang university institutional review board approval (No. 2017-07-022)


2021 ◽  
Vol 27 (2) ◽  
pp. 55-60
Author(s):  
Ki Hong Kim ◽  
Hee Jo Yang ◽  
Youn Soo Jeon

Objective: To identify predictive factors for favorable outcomes after surgical treatments that were performed by beginner urologists in patients with benign prostate hyperplasia (BPH), we retrospectively evaluated outcomes after holmium laser enucleation of the prostate (HoLEP) and transurethral resection of prostate (TURP) that were performed by two young urologists.Methods: Of 80 patients who were treated with HoLEP or TURP, 31 (HoLEP) and 36 (TURP) patients who were followed up for 3 months were enrolled in this study. Preoperative and perioperative variables were evaluated to identify predictive factors for favorable outcome after surgical treatment for BPH.Results: At 3 months postoperative after HoLEP or TURP, the median decrease in International Prostate Symptom Score (IPSS) was 13.0. Patients whose IPSS decreased by over 13 points were categorized into a favorable response group after HoLEP or TURP. Univariate and multivariate logistic regression analyses were performed to identify predictors of favorable outcomes at 3 months after HoLEP or TURP, and the preoperative IPSS was identified as an independent predictor for favorable outcomes.Conclusion: When young urologists plan to perform surgical treatment for BPH, they should consider that the severity of symptoms is the most important factor for favorable outcomes. The type of surgical modality for managing BPH is less important.


Author(s):  
Bekir Voyvoda ◽  
Ömür Memik ◽  
Murat Üstüner ◽  
Onur Karslı ◽  
Levent Özcan

Objective: Our study aimed to the efficacy of silodosin in patients with LUTS associated with BPH who were not-responder to previous ARs blocker therapy. Methods: Patients who did not benefit from alpha blockers treatment, but did not want surgical treatment are included in this study. At enrollment, 75 patients and 75 patients were assigned to group 1 and group 2, respectively. Group 1 received silodosin 8 mg, group 2 received their previous α blocker. Results: Although, in group 1 mean IPSS score at baseline was 20,81±0,97, and it significantly decreased to 17,12±1,25 at third months, in group 2 no significant changes were observed. On the other hand in group 1 a decrease was also observed for both IPSS sub score was significantly reduced at third months, when it is compared with baseline. At the end of the third month, a significant improvement in this parameter was observed after switching to silodosin, as compared with first value (p< 0,05). As to the residual urine, significant improvement was observed in the silodosin group but no significant improvement was observed in group 2. Conclusion: This study was conducted to investigate the effectiveness and safety of silodosin in patients with BPH who had not achieved satisfactory symptom control with other α blockers in routine clinical practice before surgical treatment. Thus, at least patients who have different comorbidities will be protected from morbidities of surgery.


Sign in / Sign up

Export Citation Format

Share Document